Home ETF List About
ISINIE00BDZVHG35
Stock Name/CompanyiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Stock TypeETF
Country of IssueUK
Ticker SymbolBTEE (USD) - LSE
BTEE.L (GBP) - LSE
Related ETFsiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is an Equity ETF domiciled in Ireland with an ISIN of IE00BDZVHG35. The ETF is a fund of N/A managed by BlackRock Asset Management Ireland Limited. The Equity is USD currency-based and adopts a Replicated approach of tracking the NASDAQ Biotechnology Index (Net Total Return) index. The ETF structure is based on Physical assets. Income received by the ETF eg dividend follows an Distributing strategy. The ETF fund custodian is State Street Custodial Services (Ireland) Limited, and the administrator is SSB-STATE STREET DUBLIN FUND ACCOUNTING. The primary ticker for the ETF is BTEE.

This ETF gained 0.5% recently!

Based on recent adjusted close prices. Past performance is not indicative of future results.

Discover detailed technical analysis, including moving averages, RSI, and more for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

Analyze BTEE.L Trends Now

IE00BDZVHG35 ETF holdings on 2025-09-25 (Thursday)

ETF trades on 2025-09-25
ETF TickerAdjusted Close PriceOpening Price to Prev CloseNAVComment
BTEE.L6.831Price decrease-1.8%0.000Open price decrease-100.0%Data not available
Loading holdings...
Holding TickerNumber of Shares HeldValue of Shares HeldShare Price (Delta Previous)Comment
GILEAD SCIENCES INC (NASDAQ - GILD)412,774USD 45,813,786USD 110.99New holding detected
VERTEX PHARMACEUTICALS INC (NASDAQ - VRTX)119,213USD 45,523,868USD 381.87New holding detected
AMGEN INC (NASDAQ - AMGN)162,066USD 43,949,058USD 271.18New holding detected
ALNYLAM PHARMACEUTICALS INC (NASDAQ - ALNY)73,258USD 32,935,332USD 449.58New holding detected
REGENERON PHARMACEUTICALS INC (NASDAQ - REGN)58,244USD 32,355,124USD 555.51New holding detected
ASTRAZENECA ADR REPRESENTING .5 PL (NASDAQ - AZN)292,064USD 21,475,466USD 73.53New holding detected
INSMED INC (NASDAQ - INSM)119,110USD 16,150,125USD 135.59New holding detected
ARGENX SE ADR (NASDAQ - ARGX)17,259USD 12,272,702USD 711.09New holding detected
BIOGEN INC (NASDAQ - BIIB)82,654USD 11,213,668USD 135.67New holding detected
UNITED THERAPEUTICS CORP (NASDAQ - UTHR)25,495USD 10,846,083USD 425.42New holding detected
INCYTE CORP (NASDAQ - INCY)110,082USD 8,989,296USD 81.66New holding detected
ROYALTY PHARMA PLC CLASS A (NASDAQ - RPRX)243,684USD 8,504,572USD 34.90New holding detected
SUMMIT THERAPEUTICS INC (NASDAQ - SMMT)418,779USD 8,484,463USD 20.26New holding detected
ILLUMINA INC (NASDAQ - ILMN)86,657USD 7,988,909USD 92.19New holding detected
NEUROCRINE BIOSCIENCES INC (NASDAQ - NBIX)55,913USD 7,877,583USD 140.89New holding detected
Load more holdings (Load 239 more)Now loading...
Share price and value of shares held is calculated on the adjusted close price on 2025-09-25

IE00BDZVHG35 ETF holdings on 2025-09-24 (Wednesday)

ETF trades on 2025-09-24
Loading holdings...

Detail on historic holdings of IE00BDZVHG35

Shares Issued in BTEE

DateShares IssuedNum New BTEE SharesNAVMarket value of new BTEE shares issuedValue of shares added to portfolio holdingsCash or Equivalent
2025-09-253,754,627195,930 @ N/AUSD 6.82USD 0USD 0USD 968,766
GBP 104,016
EUR 5,148
2025-09-243,558,697-324,439 @ N/AUSD 6.95USD 0USD 0USD 939,068
GBP 104,823
EUR 5,177
2025-09-233,883,1360 @ N/AUSD 6.97USD 0USD 0
2025-09-223,883,1360 @ N/AUSD 7.01USD 0USD 0
2025-09-193,883,136-47,296 @ N/AUSD 6.97USD 0USD 0
2025-08-123,930,4320 @ N/AUSD 6.57USD 0USD 0USD 1,092,410
GBP 66,268
EUR 5,123
2025-08-113,930,4320 @ N/AUSD 6.48USD 0USD 0USD 1,113,800
GBP 65,875
EUR 5,078
2025-08-083,930,4320 @ N/AUSD 6.49USD 0USD 0USD 976,901
GBP 66,027
EUR 5,103
2025-08-073,930,43224,760 @ N/AUSD 6.44USD 0USD 0USD 838,981
GBP 9,920
EUR 5,089
2025-08-063,905,67264,000 @ N/AUSD 6.45USD 0USD 0USD 841,160
GBP 9,866
EUR 5,091
USD 0USD 0
The number of shares issued is based on the difference from the current number of shares and the last previous known number of shares and may not be the value of new issue shares on the date. Value of added shares to portfolio is based on adjusted close price x the number of new shares and may not be the price they were purchased at. The value of new ETF shares issued is based on the adjusted close price of the ETF - this may not be the actual price the new issues were sold for. Cash is made up of cash deposits or equivalent eg liquidity Dollars which are part of the holdings

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.